Wageningen University spin-off building scopeDx, a portable CRISPR-based molecular diagnostics platform for agri and healthcare.
| Date | Round | Amount |
|---|---|---|
| Jun 2025 | Seed Scope Biosciences closed a follow-on seed from SHIFT Invest and Oost NL, bringing total funding to €6M, to scale its CRISPR diagnostics platform scopeDx. | — |
| Oct 2023 | Seed Wageningen-based Scope Biosciences raised EUR500K led by SHIFT Invest and OostNL to commercialise its CRISPR-Cas agricultural diagnostics. | $540K |
| Nov 2021 | Funding round Dutch CRISPR-diagnostics biotech Scope Biosciences raised EUR 1M from GenDx to develop and market its ScopeDx platform. | $1.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.